Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0584
-0.0016 (-2.67%)
At close: Oct 14, 2026
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $4.1 million as of October 15, 2026. It is the 45,738th most valuable company in the world and the 6,125th biggest in the United States. Its market cap has increased by 358.44% in one year.
Market Cap
4.10M
Enterprise Value
31.81M
Revenue
15.53M
Global Rank
Country Rank
#6,125 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 4.10M, a decrease of -98.84%. That is a compound annual growth rate of -45.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 4.10M | 393.70% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Reviva Pharmaceuticals Holdings | 6.49M |
| Hepion Pharmaceuticals | 5.99M |
| LianMedical | 5.52M |
| Eastgate Biotech | 5.29M |
| Institute of Biomedical Research | 4.95M |
| Vaxxinity | 4.37M |
| Nymox Pharmaceutical | 3.36M |
| Pacific Software | 3.12M |